FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13205111000001107: Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
46466301000001114 Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
46466401000001118 Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Is a Generic Stalevo 100mg/25mg/200mg tablets true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has active ingredient Entacapone false Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Is a Stalevo true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has specific active ingredient Carbidopa true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has specific active ingredient Entacapone true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) 100 tablet Is pack of False Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Inferred relationship Existential restriction modifier
Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) 100 tablet Has AMP True Stalevo 100mg/25mg/200mg tablets (Dowelhurst Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start